Acquired factor V inhibitors after allogeneic hematopoietic stem cell transplantation in a dog
Abstract Objective Describe the clinical course and management of a dog that underwent hematopoietic stem cell transplantation (HSCT) for treatment of B‐cell lymphoma and developed acquired circulating factor V (FV) inhibitors. Case Summary An 8‐year‐old male castrated Briard dog diagnosed with lymp...
Main Authors: | Joseph Masciana, Nathan Peterson, John Chretin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Journal of Veterinary Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1111/jvim.15845 |
Similar Items
-
Executive Summary of Recommendations and Expert Consensus for Plasma and Platelet Transfusion Practice in Critically Ill Children: From the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding (TAXI-CAB)
by: Bateman, S.T, et al.
Published: (2022) -
Allogeneic hematopoietic stem cell transplantation: transfusion issues
by: Akkök ÇA
Published: (2016-05-01) -
Hemostatic Balance in Pediatric Acute Liver Failure: Epidemiology of Bleeding and Thrombosis, Physiology, and Current Strategies
by: Yonca Bulut, et al.
Published: (2020-12-01) -
Trauma-induced coagulopathy: prospective observation study
by: Mariana Vyshynska
Published: (2021-07-01) -
Use of a high platelet-to-RBC ratio of 2:1 is more effective in correcting trauma-induced coagulopathy than a ratio of 1:1 in a rat multiple trauma transfusion model
by: Derek J. B. Kleinveld, et al.
Published: (2019-07-01)